Finance

Lists
4886:TYO
ASKA Pharmaceutical Holdings Co Ltd
2 056,00 JPY
+0,44%
(+9,00) 1D
30 სექ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4886...
Open
2 043 JPY
High
2 071 JPY
Low
2 025 JPY
Mkt. cap
59,14 მლრდ.
Avg. vol.
61,69 ათ.
Volume
45,10 ათ.
Dividend
2,92%
Quarterly dividend
15 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
12,39
52-wk high
3 045 JPY
52-wk low
1 917 JPY
EPS
166 JPY
No. of employees
2 ათ.
Open
2 043 JPY
High
2 071 JPY
Low
2 025 JPY
Mkt. cap
59,14 მლრდ.
Avg. vol.
61,69 ათ.
Volume
45,10 ათ.
Dividend
2,92%
Quarterly dividend
15 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
12,39
52-wk high
3 045 JPY
52-wk low
1 917 JPY
EPS
166 JPY
No. of employees
2 ათ.
About ASKA Pharmaceutical Holdings Co Ltd
CEO-
Employees1,61 ათ.
Founded1 აპრ. 2021
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
15,93 მლრდ.
19,23 მლრდ.
16,64 მლრდ.
17,38 მლრდ.
Cost of goods sold
7,58 მლრდ.
9,89 მლრდ.
8,82 მლრდ.
9,30 მლრდ.
Cost of revenue
7,58 მლრდ.
9,89 მლრდ.
8,82 მლრდ.
9,30 მლრდ.
Research and development expenses
-
-
7,06 მლრდ.
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,18 მლრდ.
7,08 მლრდ.
-140,00 მლნ.
7,38 მლრდ.
Operating expense
7,18 მლრდ.
7,08 მლრდ.
6,90 მლრდ.
7,38 მლრდ.
Total operating expenses
14,76 მლრდ.
16,97 მლრდ.
15,72 მლრდ.
16,67 მლრდ.
Operating income
1,17 მლრდ.
2,26 მლრდ.
922,00 მლნ.
712,00 მლნ.
Other non operating income
83,00 მლნ.
-24,00 მლნ.
54,00 მლნ.
67,00 მლნ.
EBT including unusual items
1,04 მლრდ.
2,19 მლრდ.
2,04 მლრდ.
817,00 მლნ.
EBT excluding unusual items
1,11 მლრდ.
2,12 მლრდ.
811,00 მლნ.
817,00 მლნ.
Income tax expense
2,00 მლნ.
546,00 მლნ.
445,00 მლნ.
284,00 მლნ.
Effective tax rate
0,19%
24,90%
21,80%
34,76%
Other operating expenses
-
-
-
-
Net income
982,00 მლნ.
1,68 მლრდ.
1,52 მლრდ.
533,00 მლნ.
Net profit margin
6,16%
8,72%
9,13%
3,07%
Earnings per share
-
-
-
-
Interest and investment income
-
164,00 მლნ.
30,00 მლნ.
194,00 მლნ.
Interest expense
-88,00 მლნ.
-53,00 მლნ.
-60,00 მლნ.
-93,00 მლნ.
Net interest expenses
-88,00 მლნ.
111,00 მლნ.
-30,00 მლნ.
101,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,89 მლრდ.
-
1,69 მლრდ.
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები